Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent will provide support for the development, manufacturing, and clinical supply of Editas Medicine’s current and future portfolio of in vivo CRISPR medicines and engineered cell medicines.
read more
Intravacc and Celonic have signed a research agreement to further design, develop and produce a Covid-19 vaccine.
read more
Wednesday, August 05, 2020
Horizon Discovery announced TrueBinding has signed a set of commercial licenses for Horizon’s cGMP-compliant CHOSOURCE platform.
read more
Wednesday, August 05, 2020
The FDA proposed to include four bulk drug substances on the list of bulk drug substances that outsourcing facilities may use in drug compounding consistent with section 503B of the Federal Food, Drug & Cosmetic Act.
read more
The FDA has announced the retirement of the MedWatch to Manufacturer Program.
read more
Catalent will expand its Argentinian site in Loma Hermosa, Buenos Aires.
read more
Bora Pharmaceuticals has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more
Iovance Biotherapeutics has selected Avid to provide process development, pilot-batch manufacturing and CGMP manufacturing services to support development of IOV-3001.
read more
Wednesday, August 12, 2020
Caprion-HistoGeneX and Viroclinics-DDL have announced a partnership that will offer global, integrated services to support discovery and development of vaccines and antiviral therapies.
read more
Wednesday, August 12, 2020
Catalent announced that it has been approved by the FDA to produce commercial drug substance intermediate for AveXis’ spinal muscular atrophy gene therapy.
read more
Wednesday, August 12, 2020
Avacta Group has appointed BBI Solutions to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva.
read more
Thursday, August 13, 2020
Novel and generics pharma producer OncoGenerix and Alpha Capital have come to an agreement to build a new injectable pharmaceutical factory in the US.
read more
Thursday, August 13, 2020
Ajinomoto Bio-Pharma has announced an expansion of small molecule manufacturing capabilities with the addition of a new production facility in India.
read more
Thursday, August 13, 2020
Eyenovia has entered into a license agreement for Arctic Vision to develop and commercialize MicroPine in Greater China and South Korea.
read more
Bioanalytical Systems, doing business as Inotiv, announced I.M. Grossi, Ph.D., has joined the Company as Vice President, Toxicology.
read more